title: Hypersensitivity to lansoprazole with tolerance to other proton pump inhibitors: does cross-reactivity between proton pump inhibitors really exist?
authors.forename: E
authors.initials: E
authors.lastname: Karabacak
authors.forename: A
authors.initials: A
authors.lastname: Kutlu
authors.forename: E
authors.initials: E
authors.lastname: Aydin
authors.forename: S
authors.initials: S
authors.lastname: Ozturk
mesh_terms: D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry; D000328:Adult; D000707:Anaphylaxis / Q000209:etiology / Q000517:prevention & control*; D003429:Cross Reactions; D004342:Drug Hypersensitivity / Q000150:complications / Q000175:diagnosis* / Q000276:immunology; D005260:Female; D006801:Humans; D007108:Immune Tolerance; D007114:Immunization; D064747:Lansoprazole; D010437:Peptic Ulcer / Q000150:complications / Q000188:drug therapy*; D054328:Proton Pump Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects / Q000737:chemistry; D012882:Skin Tests
chemical_list: D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D054328:Proton Pump Inhibitors; D064747:Lansoprazole